Entasis Therapeutics to Present at Upcoming June 2017 Investor Conferences

WALTHAM, Mass.--(BUSINESS WIRE)-- Entasis Therapeutics, a leader in the discovery and development of breakthrough anti-infective products, today announced that CEO, Manos Perros will present at two upcoming investor conferences in June, the Jefferies Global Healthcare Conference taking place in New York, NY on June 6 to 9, and the JMP Securities Life Sciences Conference on June 20 to 21, also taking place in New York City.

Details of the presentations are as follows:

Jefferies Global Healthcare ConferenceDate: Tuesday, June 6, 2017Time: 2pm ETForum: Corporate PresentationLocation: New York

JMP Securities Life Sciences ConferenceDate: Wednesday, June 21, 2017Time: 12:30pm ETForum: Panel Discussion on AntibioticsLocation: New York

About Entasis Therapeutics Inc.Entasis Therapeutics is developing a portfolio of innovative cures for serious drug-resistant bacterial infections, a global health crisis affecting the lives of millions of patients. Entasis’ anti-infective discovery platform has produced a pipeline of meaningfully differentiated programs which target serious bacterial infections, including ETX2514SUL (targeting Acinetobacter baumannii infections), ETX0282CPDP (targeting Enterobacteriaceae infections), and zoliflodacin (targeting Neisseria gonorrhoeae). www.entasistx.com

View source version on businesswire.com: http://www.businesswire.com/news/home/20170531005301/en/

Company Contact
Entasis Therapeutics
Kyle Dow, 781-810-0114
[email protected]
or
Media Contact
MacDougall Biomedical Communications
Kari Watson, 781-235-3060
[email protected]

Source: Entasis Therapeutics

You May Also Be Interested In

• Small Essential, Big Difference: How Modofo Makes Everyday Drinkware More Stylish
• Marina Bay Sailing Team Building for 8 to 48 Pax
• Watershed Roofing Inc. Expands Roofing and Exterior Services Across British Columbia